Pharma Asset Sales and Split-Ups Could Unlock Value but Weaken Credit Profiles
While drug-makers face increasing pressure to divest non-pharmaceutical businesses, selling assets may undermine credit ratings by reducing business diversity and scale, according to a new report from Moody’s Investors Service. As share prices remain depressed some pharma giants may sell assets in order to fund share repurchases and dividends, while others may [...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here